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Abstract
Background: Concurrent aerobic and resistance training (CART) programs have been widely recommended as an
important strategy to improve physiologic and functional performance in patients with chronic diseases. However,
the impact of a personalized CART program in patients with type 2 diabetes (T2D) requires investigation. Therefore,
the primary aim of the current study is to investigate the impact of CART programs on metabolic profile, glycemic
control, and exercise capacity in patients with diabetes.
Methods: We evaluated 41 subjects with T2D (15 females and 19 males, 50.8 ± 7 years); subjects were randomized
into two groups; sedentary (SG) and CART (CART-G). CART was performed over 1.10-h sessions (30-min aerobic and
30-min resistance exercises) three times/week for 12 weeks. Body composition, biochemical analyses, peripheral
muscular strength, and cardiopulmonary exercise testing were primary measurements.
Results: The glycated hemoglobin HbA1c (65.4 ± 17.9 to 55.9 ± 12.7 mmol/mol), cholesterol (198.38.1 ± 50.3 to 186.
8 ± 35.1 mg/dl), and homeostasis model assessment insulin resistance (HOMA-IR) (6.4 ± 6.8 to 5.0 ± 1.4) decreased in
the CART-G compared to the SG. Although body weight did not significantly change after training, skinfold
measurement indicated decreased body fat in the CART-G only. CART significantly enhanced muscle strength
compared to the SG (p < 0.05). CART was also associated with significant increase in peak oxygen uptake and
maximal workload compared to the SG (p < 0.05).
Conclusions: These data support CART as an important strategy in the treatment of patients with T2D,
producing both physiologic and functional improvements.
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Key Points
 Concurrent aerobic and resistance training has
important translational implications for the
management of diabetic patients
 A 12-week supervised, individualized, and personal-
ized concurrent aerobic and resistance training
improves glycemic control, body composition, and
functional capacity parameters, including oxygen
uptake and muscle strength, in diabetic patients
 Changes in peak VO2 could predict 21 % of the
changes expected for HbA1c, which can explain the
link between metabolic profile and exercise
performance using a concurrent aerobic and
resistance training program
Background
In Brazil, type 2 diabetes (T2D) currently assumes a
prominent position among the non-communicable dis-
eases, affecting 11.3 million people in 2011; projections
indicate that this number is likely to triple by 2030 [1].
In view of this scenario, lifestyle interventions that in-
clude change in diet, exercise, and education hold sig-
nificant benefit in reducing cardiovascular risk factors in
patients with T2D [2].
In particular, exercise training (ET) has long been consid-
ered a cornerstone in the management of T2D [3]. Aerobic
and resistance activities produce differing metabolic and
molecular responses [4]. It is well established that the exer-
cise increases skeletal muscle glucose uptake through an
insulin-independent pathway [5], indicating muscle con-
traction directly impacts glucose homeostasis. In fact, skel-
etal muscle plays a primary role in glycemic control and
metabolic homeostasis, being a predominant site of glucose
disposal under insulin-stimulated conditions [6]. Although
aerobic and resistance exercise are individually capable of
promoting substantial health benefits, the signaling path-
ways and physiologic effects are specific to training mode
[4]. Aerobic exercise improves mitochondrial biogenesis
[7], the intrinsic oxidative capacity of muscle, and the de-
livery and utilization of substrates in working muscle [8, 9].
Conversely, resistance exercise induces morphological and
neurological adaptations which contribute to changes in
muscle neural firing pattern, size (i.e., hypertrophy), and
function (i.e., strength and power) [10, 11].
Ideally, both aerobic and resistance components are
included in an individualized ET program [3]. Inclusion
of both aerobic and resistance ET improves aerobic cap-
acity/performance, muscle strength, and endurance and
preserves muscle mass [12], all importantly contributing
to improvements in cardiovascular risk profile, morbid-
ity, and mortality [13].
In a well-designed study with a statistically robust
sample size, Sigal et al. observed that combined aerobic
and resistance training over a long period was superior
to either mode in isolation in improving glycemic
control [14]. However, in this study, although there was
a progression of training intensity, combined training
was only individually applied during the first 4 weeks,
and the type, order, and progression of resistance exer-
cises prescribed were not clear and were not well de-
scribed. Church et al. observed that a combined exercise
training program was more effective in improving
HbA1c [15]. Although the authors clearly describe the
intensity of aerobic and resistance training as well as the
types of resistance exercises, the daily sequence of train-
ing as well as progression was unclear. Such details are
very important when considering the optimization of re-
sults, especially for short-duration training programs.
In 1980, Hickson was the first to investigate the effects
of a concurrent exercise training program, which com-
bined aerobic and resistance components during the
same session [16]. Recently, programs that combine aer-
obic and resistance training have been investigated with
a focus on optimizing outcomes, i.e., the magnitude of
physiologic and clinical improvements. Recent evidence
indicates concurrent ET leads to less than optimal im-
provements in muscle strength [17]. In addition, other
studies have found concurrent ET leads to less than op-
timal improvements in peak oxygen uptake (VO2) in
healthy males [18].
To our knowledge, it is unclear whether concurrent
training can enhance or impair parameters of strength
and aerobic capacity in patients with T2D. In addition, it
is unclear if a concurrent ET training program imple-
mented for a short period could produce positive adap-
tations, while considering aspects such as an
individualized training approach during supervised ses-
sions, taking into account the order of application. As
such, addressing these issues is the primary objective of
the current investigation. We hypothesize that a well-
designed, short duration, concurrent ET program can
lead to a reduction in HbA1c as well as improvements
in peak VO2, peripheral muscle strength, and cardiovas-
cular risk profile in a T2D cohort.
Methods
Design, Recruitment Process, and Population
Participants were recruited through word of mouth,
radio advertisements, local e-mail subscription services,
social media, and flyers. All potential participants were
screened for exclusion criteria via telephone scripts and
face-to-face interviews.
The current investigation recruited and enrolled a
total of 41 patients (15 females and 19 males) with a
confirmed diagnosis of T2D, aged 51 ± 7 years. Duration
of T2D was based on a self-reported date of diagnosis.
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The experimental procedures were performed in the
Cardiopulmonary Physiotherapy Laboratory at the Fed-
eral University of São Carlos, and blood collection was
performed at the Clinical Analysis Laboratory in the
same location.
Eligibility criteria were (1) established diagnosis of
T2D confirmed by a physician and (2) a sedentary life-
style for at least 6 months according to the American
Heart Association criteria [19]. Exclusion criteria con-
sisted of (1) a confirmed diagnosis of any heart disease,
(2) uncontrolled hypertension, (3) any musculoskeletal
disorders, (4) any confirmed diagnosis of respiratory dis-
ease, and (5) confirmed autonomic neuropathy. Auto-
nomic neuropathy was considered when the patient
presented with a clinical diagnosis and/or heart rate
>100 bpm [20] and a validated symptomatology 7 ques-
tion tool [21]. The study followed the Declaration of
Helsinki guidelines and was approved by the Human Re-
search Ethics Committee of our Institution (protocol
number 1318/1). The procedure was explained and sub-
jects subsequently confirmed their participation in the
study by written informed consent. Written informed
consent was obtained from the patient for publication of
this original manuscript and any accompanying images.
Randomization
The current study is a randomized controlled trial
(RCT) (RBR 492q8z) available from http://www.ensaio-
sclinicos.gov.br/rg/?q=RBR-492q8z. Allocation was per-
formed by a person not involved in the study selecting
the envelope from a box. Participants included in the
study were randomized by 41 sealed opaque envelopes,
21 to the concurrent ET group (CART-G) and 20 to the
sedentary group (SG). Subjects were randomized in an
equal ratio (1:1) with a random block size of 4.
The data were analyzed by a specialist who was
blinded to participant group allocation.
Outcomes
Primary outcome: The primary outcome measures were
change in HbA1c, peal VO2, and biochemical analyses in
T2D patients after a 12-week concurrent ET program.
Secondary outcome: As a secondary outcome measure,
we analyzed changes in peripheral muscle strength
and body composition following a 12-week concurrent
ET program.
Procedures and Data Collection
All subjects were evaluated during the same time of the
day (in order to consider differences in response due to
circadian rhythm) in an experimental room with a
temperature of 22 °C and relative air humidity between
50 and 60 %.
Skinfold Thickness
Skinfolds of the biceps, triceps, subscapular, suprailiac,
abdomen, and thigh were measured thrice using metal
calipers (Cescorf, Porto Alegre, Rio Grande do Sul,
Brazil). The average of the three skinfold measurements
was used for calculation of percent body fat [22].
Body Circumferences
The circumference of the arm, axillary, xiphoid, hip,
waist, and thigh was measured using a flexible tape
measure with 0.1-cm increments. Waist circumference
was measured at the level of the umbilicus and the hips
at the level of the iliac crest taken with the patient in a
standing position. All measurements were performed
thrice by a researcher who had been previously trained
and certified to perform these procedures; the average of
the three measurements was used for calculation [22].
Body composition was assessed by bioelectrical imped-
ance analysis using the Tanita Bc533 and previously de-
scribed methodology [23, 24].
Biochemical Measurements
Blood specimens were obtained after an overnight fast
for all measurements. HbA1c was measured in a central
laboratory by anion exchange high-performance liquid
chromatography (Variant II, BioRad, Berkeley, CA),
coupled with a fluorescence detector method certified by
the National Glycohemoglobin Standardization Program
[25]. Fasting plasma glucose was measured by an enzym-
atic method using an AU 680® (Beckman Couter, Suarlée
(NAMUR) Belgium), and fasting plasma insulin was
measured by a chemiluminescent assay (UniCel® DxI
800, Pasadena, CA). Total cholesterol (total-C), low-
density lipoprotein cholesterol (LDL-C), high-density
lipoprotein cholesterol (HDL-C), and triglycerides were
measured by an enzymatic method AU 680® (Beckman
Couter, Suarlée (NAMUR) Belgium) [26].
Cardiopulmonary Exercise Testing (CPX)
A symptom-limited incremental exercise test was per-
formed on a cycle ergometer (Recumbent Corival of
MedGraphics, MN, USA) with the collection of gas ex-
change and ventilatory variables using a calibrated
computer-based exercise system (Metabolic analyzer
System Greenhouse telemetry module for field studies
Oxycon-Mobile, Jaeger, Hoechberg, Germany).
The day before CPX, the subjects were taken to the
experimental room for familiarization with the proce-
dures and equipment to be used. All subjects were
instructed to (1) avoid caffeinated and alcoholic bever-
ages or any other stimulants the night before and the
day of data collection, (2) not to perform activities re-
quiring moderate-to-heavy physical exertion on the day
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before data collection, and (3) not to speak unnecessarily
during the evaluation to avoid HR signal interference.
The exercise test consisted of (1) 5 min of rest, (2)
4 min with real “zero” workload, obtained by means of a
system which moves the ergometer freewheel at 60 revo-
lutions per minute (rpm), (3) the incremental phase, (4)
1 min active recovery period, and (5) 5 min passive
recovery period. The workload (W) was continuously
increased in a linear “ramp” pattern of 15 W min−1
[27], so that the incremental exercise testing duration
was between 8 and 12 min [28]. The test finished
when subjects reached physical exhaustion or demon-
strated abnormal test responses that warranted test
termination [27].
Peak VO2 was defined as the highest 15-s average
value during the test [29]. Fifteen-second averaged venti-
lation (VE) and carbon dioxide production (VCO2) data,
obtained from the initiation of exercise to peak, were in-
putted into a spreadsheet software (Microsoft Excel,
Microsoft Corp., Bellevue, WA, USA). VE and VCO2 re-
sponses throughout exercise were used to calculate the
VE/VCO2 slope via least squares linear regression (y =
mx + b, m = slope) [30].
Isokinetic Strength Test
Isokinetic concentric knee-extensor strength on the
dominant side was performed at a speed of 60°/s using
an isokinetic dynamometer (Biodex Medical Systems 3,
Shirley, NY). Positioning and stabilization of the subjects
was standardized. Mechanical axis of rotation of the
level arm was aligned to the axis of rotation of the joint
being tested. The resistance pad at the end of the level
arm was strapped to the most distal part of the tibia.
Correction for the effect of gravity was made. After
stretching, a warm-up exercise was performed on the
dynamometer. The order of peripheral muscle tests ap-
plied was as follows: (1) Protocol 1, which was for the
analysis of the maximal isokinetic strength, the volun-
teers performed five maximal efforts to determine max-
imal peak torque (in N m) at low angular velocity (U) of
60°/s; (2) Protocol 2, which was for the analysis of iso-
kinetic endurance, the participants performed efforts for
1 min at a high angular velocity of 300°/s to determine
average power (in W). This protocol assessed muscular
efficiency and total work (in J) [31].
One-Repetition Maximum Test (1-RM)
To determine protocol loads, the 1-RM test was
applied by gradually increasing resistance until the
volunteer succeeded in performing no more than one
repetition [32]. The 1-RM test was performed for all
eight exercises.
Concurrent Aerobic and Resistance Training Program
(CART)
The training protocol for the CART-G consisted of
individually supervised sessions on alternate days,
~210 min/week, three times per week, for 12 weeks,
totaling 36 sessions.
All training sessions were carried out under the individ-
ual supervision of exercise specialists. Each session lasted
~1 h and 10 min and included a (1) 5-min warm-up, (2)
60-min CART training, and (3) 5-min cool down. The
protocol was performed for three separate sessions before
determination of the 1-RM to allow familiarization of
equipment. In order to avoid a bias effect during the
training program, during each exercise session day, the
subjects alternated the order of training (i.e., aerobic train-
ing first followed by resistance training and subsequently
resistance training followed by aerobic training). Resist-
ance training was performed at 60–80 % of predicted 1-
RM [33] and consisted of eight resistance exercises target-
ing all major muscle groups as recommended by the
American Diabetes Association [34]. Subjects performed
sets of four upper body exercises (biceps free weights;
seated row; triceps and, flat bench press) and three sets of
four lower body exercises (leg press; leg extension; calf
and, seated leg curl). Each maneuver consisted of three
sets of 10–12 repetitions. The amount of weight lifted was
progressively increased through sessions in order to main-
tain consistent repetitions during the training program.
The participants were advised to rest 2 to 3 min between
sets to allow for maximal muscle recovery.
Aerobic training was performed at the HR correspond-
ing at 60–70 % of peak VO2 assessed by CPX. Each
training session was 30 min in duration [34].
The workload during both aerobic and resistance train-
ing was gradually increased after experimental measures.
Skinfold thickness, body circumferences, biochemical
measurements, CPX isokinetic strength test, and the 1-
RM test were assessed at the midway point of the protocol
(i.e., sixth week). Table 1 lists the CART progression.
Heart rate, blood pressure, and blood glucose mea-
surements were monitored pre and post exercise
sessions, in order to identify any adverse events. If
blood glucose was >13.9 mmol/l (250 mg/dl) prior to
exercise, the session was canceled. If blood glucose
was >13.9 mmol/l more than two times in a same
week, the subject was referred for a physician visit. All
the subjects completed 36 sessions. Following the 12-
week CART protocol, the subjects were re-evaluated.
All participants were instructed to maintain their
usual medical care and they received dietary advice
on healthy eating [35], but there was no specific diet-
ary intervention with regard to eating habits. Subjects
were given the opportunity to miss or cancel sessions
with a makeup session scheduled as soon as possible.
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In this context, the duration of the program did not
exceed 12 weeks.
Statistical Analysis
Sample size calculation, based on a previous study [15],
suggested that recruitment of 12 patients in each group
would provide sufficient statistical power for the primary
endpoint (i.e., peak VO2). The power (80 %) at an α-
level of 0.05 to detect a significant difference in peak
VO2 (ml kg
−1 min−1) of ~1.2 ml kg−1 min−1 between
groups was used.
The sample size was determined a priori through GPo-
wer software 3.1.9. Considering the main outcome was
the mean difference between groups and times (analysis of
variance (ANOVA): repeated measures, within-between
interaction, effect size = 0.40, with α = 0.05, β = 80 %, d =
0.8) and the allocation ratio was 1:1, the calculated sample
size was 16 for each group. Anticipating a dropout rate,
more subjects were recruited in each group.
Data are presented as mean and standard deviation
after testing for normal distribution by the Shapiro-Wilk
test. Differences between the two groups (SG versus
CART-G data) were assessed by unpaired Student’s t
test.
Significance of between-group differences in medica-
tion changes was evaluated by Fisher’s exact test for cat-
egorical variables.
The effect of time (pre compared with post
3 months, p, i.e., effect of CART), group (SG com-
pared with CART-G), and interaction between time
and group effects were evaluated by two-way ANOVA
for repeated measures.
Pearson’s correlations were tested to contrast the asso-
ciation between changes in variables pre and post
training, followed by linear regression. All other data
analysis was performed using the STATISTICA 5.5 soft-
ware package (Stat Soft®) and SigmaPlot® 11. The level of
significance was set at P ≤ 0.05 for all statistical tests.
The magnitude of the correlations was determined
considering the following classification scheme for r
values: ≤0.35 low or weak, 0.36 ≤ 0.67 moderate, ≥0.68
strong or high, ≥0.9 very high, and 1 perfect [36]. The
probability of a type I error was established at 5 % for all
tests (α = 0.05).
Subjects included in the final analysis had at least 80 %
adherence to their exercise prescription over the 12-
week protocol; there was 100 % adherence in CART-G
Results
Sixty participants were screened; before the randomization,
12 more were excluded, 4 not meeting inclusion criteria, 4
declining to participate, and 4 living too far of a distance
for data collection. Forty-eight subjects underwent
randomization. Post-randomization but prior to training,
two additional participants were excluded in the CART-G,
one due to gynecologic surgery and the other voluntarily
withdrew during the first week of training. Five withdrew
from the SG post-randomization, one for personal reasons,
one started to use insulin, and three moved to another city.
All remaining 41 volunteers successfully completed the
study, 20 in the control and 21 in the CART-G. No adverse
events were identified during the protocol application. The
randomization flow chart is illustrated in Fig. 1.
As summarized in Table 2, there were no statistically
significant differences in anthropometric and demo-
graphic characteristics, risk factors and/or medications
between the two groups at baseline, demonstrating suc-
cessful randomization.
A two-way ANOVA was conducted to examine the ef-
fect of time (effect of pre and post 3 months) and group
(SG vs. CART-G) on metabolic profile, glycemic control,
peripheral muscular strength, and exercise capacity sta-
tus. In Table 3, in relation to body composition, there
were no differences in weight and BMI post exercise.
However, visceral fat decreased significantly in the
CART-G only (10.9 ± 4.1 to 9.7 ± 4.2–11 %).
Also, HbA1c decreased by 9.9 % (65.4 ± 17.9 to 55.9 ±
12.7 mmol/mol) in the CART-G compared to baseline.
Comparing the post-intervention difference between the
SG and CART-G, the difference in HbA1c reached
17.1 % (72.5 ± 20.9 to 55.9 ± 12.7 mmol/mol). Moreover,
LDL/HDL decreased in the CART-G (P < 0.05) while
LDL/HDL and total cholesterol increased in the SG.
There was only a difference in resting systolic blood
pressure (SBP) (129.7 to 118 mmHg) after CART-G,
with no change in diastolic blood pressure (DBP).
All skinfolds decreased post exercise according to time
and group [(i.e., interaction time (effect of exercise) vs.
Table 1 Pearson correlation between HbA1c post X skinfold
post in the CART group
Aerobic Resistance
Weeks Intensity (VO2) (%) Duration (min) Intensity Sets/repetitions
1 60 30 60 % 1-RM 3/10
2 60 30 60 % 1-RM 3/10
3 65 30 70 % 1-RM 3/10–12
4 65 30 70 % 1-RM 3/10–12
5 70 30 75 % 1-RM 3/10–12
6 70 30 75 % 1-RM 3/12
7 70 30 75 % 1-RM 3/12
8 70 30 75 % 1-RM 3/12
9 80 30 80 % 1-RM 3/10
10 80 30 80 % 1-RM 3/10–12
11 80 30 80 % 1-RM 3/10–12
12 80 30 80 % 1-RM 3/12
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group (SG vs. CART-G), (p < 0.05)]. However, arm, um-
bilicus, hip, and thigh circumferences did not decrease
after 3 months of exercise.
After 3 months, CART-G increased relative and abso-
lute peak VO2 by 18.7 % [22.9 ± 6.1 to 27.2 ± 4.7 ml kg
−1 min−1(p = 0.002)] as well as peak workload (p ≤ 0.001),
VE (p ≤ 0.001), VCO2 (p = 0.004), and the VE/VCO2 slope
(p = 0.006). These statistical differences, according to
time and group [(i.e., interaction time (effect pre and
post) vs. group (SG vs. CART-G)], describe the simul-
taneous positive influence of a supervised, individualized
CART program on VO2 (Table 4).
Finally, the CART-G demonstrated a significant im-
provement in peripheral muscle strength; peak torque to
body weight ratio extensors by 17.2 % (167 ± 41.5 to 195.8
± 43.6 %), peak torque to body weight ratio flexors by
32 % (87.9 ± 14.7 to 116 ± 30.1 %), and total work flexion
increase by 26 % (1340.3 ± 453.8 to 1685 ± 717.1 J)
(Table 5). Interestingly, the difference between groups in
muscular strength, after 3 months, was observed only in
the flexor muscles, also evidenced by peak torque to body
weight ratio (SG = 89.5 ± 19.1 % vs. CART-G = 116 ±
30.1 %). The 1-RM test increased for all equipment when
compared pre and post CART-G (Table 6).
Peak VO2 was correlated negatively with HbA1c
(Fig. 2). Correlations between triceps, biceps, subscapu-
lar, suprailiac and, abdominal skinfolds, and HbA1c were
low to moderate (Table 7). No significant correlations
were found between parameters of body composition,
strength and insulin resistance.
Discussion
Several aspects making this an innovative investigation
(1) demonstrated that a 12-week supervised, individual-
ized, and personalized CART significantly improved (1)
glycemic control, (2) body composition, (3) peak VO2,
and (4) muscular strength. Additionally, peak VO2 was
correlated with HbA1c. This is the first study, to our
knowledge, that assessed CART using an individualized,
supervised approach over a 12-week period. Further-
more, there was 100 % adherence to the program.
In type-1 diabetes patients with poor glycemic control,
Tagougui et al. concluded that the glycation of
hemoglobin itself could play a role in reducing the gain
in peak VO2. Additionally, it was demonstrated that
poor glycemic control during exercise blunted the deox-
yhaemoglobin (HHb) increase, indicating lower muscle
oxygen extraction and a higher oxygen affinity for gly-
cated hemoglobin [37]. Furthermore, it has been shown
that increased VO2 peak is associated with decreased
cardiovascular and all-cause mortality [38]. From a
clinical perspective, our data indicate that CART can
be an effective strategy in reducing cardiovascular
risk factors with potential beneficial effects on VO2 and
peripheral muscle strength in patients with T2D.
Fig. 1 Flowchart with randomization study
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Effect of CART on Body Composition
The findings of the current study demonstrated that
body weight and BMI remained stable in both groups.
This is consistent with several previous studies [39–41],
demonstrating no difference in the body habitus charac-
teristics post ET with a longer training duration (9–
12 months) than the present study. However, Church
et al. studied the benefits of aerobic training, resistance
training, and a combination of both on HbA1c in
individuals with T2D and found that the combined train-
ing group had a decrease in mean weight compared to
the control and resistance training group [15]. Recently,
however, Johannsen et al. found that a resistance training
program for 9 months decreased body weight more than
aerobic exercise; the authors attributed this finding to
the increase in free fatty acids [42]. From the literature
in comparison to the current study, we observed that
previously reported training duration assessed was typic-
ally longer although a significant change in body weight
was not common.
Body weight collectively includes not only body fat but
also muscle, bone, and water. From this perspective,
skinfold thickness measures may be a more sensitive and
direct measure of cardiovascular risk profile (i.e., more
accurately identifying adiposity profile). Moreover,
changes in adiposity or total body fat are more relevant
regarding risk reduction compared to quantification of
body weight reduction alone [43]. In the present study,
despite the fact that body weight did not change, we ob-
served that all skinfold measurements decreased and
muscular strength improved, with these data collectively
speculating that CART might reduce adiposity and
increase lean body mass, which are considered to be
highly favorable adaptations in patients with T2D.
In this way, Boule et al. performed a meta-analysis
that systematically reviewed and quantified the effect
of exercise on HbA1c and body mass in T2D, con-
cluding that exercise programs longer than 8 weeks
reduce HbA1c, although there appears to be no
change in body mass [44].
Effect of CART on Glycemic Control
Surprisingly, at baseline, all study subjects had a poor
glycemic control, as demonstrated by HbA1c, which re-
mains the gold standard for assessing glucose homeosta-
sis as an integration of both fasting and postprandial
glucose variations over a 3-month period [45]. Although
all subjects were diagnosed with T2D, they are under use
of hypoglycemiants, some using more than one. Thus,
we expected that this cohort presented with better gly-
cemic control. In addition, all the participants were
under the routine care of an endocrinologist and seen
on a monthly basis for medical management.
Although few studies has found an improvement in
HbA1c after a combined ET program, the subjects en-
rolled were prescribed insulin and utilized pneumatic
machines [46] or elastic bands [47] or the time of the
intervention was longer [14, 15]. Thus, the protocol used
in the current study, and therefore the results, may not
be generalizable to these previous protocols. In addition,
Church et al. and Sigal et al. found that a long period of
combined ET program could beneficially modulate
HbA1c. However, our study seems to be the first to find
an important reduction in HbA1c using short-term
CART, which has implications for program costs needed
for implementation [14, 15].
Each 1 % increment of HbA1c corresponds to a
29 mg/dl increase in mean glucose concentration [48].
Conversely, an absolute decrease of 1 % in HbA1c levels
Table 2 Anthropometric and demographic data, risk factors,
and medications of the sedentary (SG) and the concurrent
aerobic and resistance training groups (CART)
Variables SG (N = 20) CART-G (N = 21) P
Age (years) 52.1 ± 7.3 49.5 ± 6.1 0.21
Height (cm) 167 ± 0.1 169 ± 0.1 0.53
Weight (kg) 85 ± 18.6 82.2 ± 19.4 0.63
BMI (kg/m2) 30.4 ± 5.8 30.1 ± 5.4 0.28
Duration type 2 diabetes (years) 7.4 ± 5.8 5.7 ± 5.5 0.17
SBP rest (mmHg) 131.1 ± 16.5 129.7 ± 15.8 0.79
DBP rest (mmHg) 89.4 ± 8.0 92 ± 11.1 0.40
HR (bpm) 83 ± 12.5 85.5 ± 13.1 0.54
Risk factors % (n)
Tabagism 0 0 –
CAD family history 20 (4) 23.8 (5) 1.00
Dyslipidemia 50 (10) 42.8 (9) 0.75
Obesity 55 (11) 38 (8) 0.35
SAH 60 (12) 47.6 (10) 0.53
Medications
Hypoglycemiants % (n)
Biguanides 95 (19) 85.7 (18) 0.60
Sulfonylurea 45 (9) 47.6 (10) 1.00
Antihypertensive
ACE I inhibitors 15 (3) 14.3 (3) 1.00
Renin inhibitors 1.00
ARAII 25(5) 20 (4) 0.71
Diuretics 5 (1) 9.5 (2) 0.60
Hypolipemiant
Estatins 15 (3) 19 (4) 1.00
Fibrates 10 (2) – 0.23
Data are reported as means ± SD. BMI body mass index, SBP systolic blood
pressure, DBP diastolic blood pressure, HR heart rate, CAD cardiovascular
disease, SAH systemic arterial hypertension, ACE I angiotensin converting
enzyme I inhibitor, ARAII angiotensin II receptor antagonists
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has been associated with a 15 to 20 % decrease in car-
diovascular events [49]. To our knowledge, this current
study is the first randomized trial to demonstrate as pro-
found a decrease in HbA1c (9.9 %) when compared to
baseline using a CART protocol and a 17.1 % when
comparing the CART-G to the SG following the trial.
More in line with the present study, Church et al.
after 9 months of aerobic and resistance training,
when compared to a non-exercise control group,
showed a reduction in HbA1c levels [15]. Sigal et al.
demonstrated the same benefits, but after 22 weeks,
where HbA1c decreased by approximately 13 %. In
the present study, considering the specificity of our
CART program, we demonstrated the same benefits
in a shorter time frame [14]. The established HbA1c
goal by an International Expert Committee [50] is
6.5 % or 47.5 mmol/mol. As such, CART may prove
to be a valuable intervention strategy to achieve this
goal. Even so, in many patients with T2D, with all the
efforts and intensive treatment, optimal glycemic con-
trol may be difficult to achieve [51, 52].
Effect of CART on Cardiorespiratory and Metabolic Profile
Awotidebe et al. previously demonstrated that patients
with T2D demonstrated a lower peak VO2 compared
with healthy controls [53]. Our findings show that exer-
cise training was associated with significant increase in
VO2 peak, which was also correlated to the decrease
in HbA1c. These findings collectively indicate that
in addition to a significant improvement in aerobic
capacity with ET [54], there is increased insulin action
[55] and improved blood glucose levels [14], which could
be due to upregulation of GLUT-4 transporter expres-
sion at a cellular level. This mechanistic pathway is of
great clinical importance, indicating the particular bene-
fit of a concurrent ET program in patients with T2D.
Similar results were demonstrated by Larose et al.
in the DARE trial, where T2D patients were randomly
Table 3 Summary of results pre and post 3 months
SG (N = 20) CARTG (N = 21) Time factor Exercise factor Interaction
Variables Pre Post Pre Post
Weight (kg) 85.0 ± 18.6 84.1 ± 17.9 82.2 ± 19.4 81.5 ± 19.5 0.64 0.06 0.80
BMI (kg/m2) 30.4 ± 5.8 30.1 ± 5.4 28.6 ± 5.2 28.3 ± 5.3 0.29 0.06 0.80
VF (%) 12.5 ± 5 12.7 ± 4.8 10.9 ± 4.1 9.7 ± 4.2‡† 0.10 0.16 0.04
HbA1c (mmol/mol ) 71.7 ± 18.9 72.5 ± 20.9 65.4 ± 17.9 55.9 ± 12.7‡† 0.04 0.08 0.03
HOMA-IR 5.6 ± 4.7 5.2 ± 4.4 6.4 ± 6.8 5.0 ± 4.4 0.84 0.05 0.31
Cholesterol (mg/dl) 196.3 ± 44.2 216.9 ± 47.9* 198.3 ± 50.3 186.8 ± 35.1 0.33 0.35 0.002
LDL/HDL (mg/dl) 2.6 ± 0.9 3.0 ± 1.1* 2.5 ± 0.5 2.4 ± 0.6† 0.2 0.2 0.03
SBP rest (mmHg) 127 ± 16.9 131.7 ± 24.6 129.7 ± 16.3 118 ± 12‡† 0.24 0.34 0.02
DBP rest (mmHg) 89.3 ± 7.3 859 ± 13.8 92.1 ± 10.5 81.8 ± 6 0.82 <0.001 0.06
Skinfold thickness (cm)
Triciptal 2.3 ± 1 2.1 ± 0.7 2.2 ± 0.6 1.6 ± 0.5‡† 0.16 <0.001 <0.001
Biciptal 1.4 ± 0.8 1.3 ± 0.6 1.3 ± 0.4 0.7 ± 0.3‡† 0.06 <0.001 <0.001
Subscapular 3.4 ± 1.1 3.6 ± 0.9 3.2 ± 0.9 2.4 ± 0.9‡† 0.02 <0.001 <0.001
Suprailiac 3.2 ± 1.3 3.5 ± 1.5 3.3 ± 1.1 2.2 ± 0.9‡† 0.11 0.003 <0.001
Abdominal 4.8 ± 1.8 4.7 ± 1.8 4.3 ± 1.6 3.1 ± 1.1‡† <0.001 <0.001 <0.001
Thigh 2.8 ± 1.0 2.7 ± 0.9 3.0 ± 1.4 1.7 ± 0.8‡† 0.34 <0.001 <0.001
Cirtometry (cm)
Arm 34.4 ± 4.2 36.1 ± 7.8 33.8 ± 3.7 33.3 ± 3.8 0.25 0.44 0.13
Axillary 108 ± 11.5 106.7 ± 11.6 105.9 ± 11.3 101.2 ± 13† 0.30 0.002 0.06
Xiphoid 102.2 ± 12.6 101.6 ± 12.5 99 ± 12.3 96.7 ± 12.5‡† 0.31 <0.001 0.02
Waist 100.8 ± 13.5 100.4 ± 13.3 95.3 ± 13 91.5 ± 13.6‡† 0.09 <0.001 <0.001
Umbilicus 105.2 ± 12.5 104.6 ± 12.1 98 ± 16.4 95 ± 11.9 0.04 0.15 0.32
Hip 104.2 ± 11.2 103.3 ± 8.6 102.9 ± 9.8 99 ± 8.7 0.33 0.02 0.17
Thigh 57.4 ± 5.4 56.7 ± 5.7 55.8 ± 7.5 56.7 ± 6.1 0.70 0.91 0.22
Data are reported as means ± SD. BMI body mass index, HOMA-IR homeostatic model assessment insulin resistance, LDL/HDL low-density lipoproteins/high-density
lipoproteins, SBP systolic blood pressure, DBP diastolic blood pressure, mmHg millimeter of mercury. P ≤ 0.05, *sedentary group pre × sedentary group post; ‡exercise
group pre × exercise group post, †sedentary group post × exercise group post
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allocated into aerobic, resistance, or aerobic plus resist-
ance training groups. This study demonstrated a link be-
tween positive changes in VO2 and HbA1c in the
combined aerobic and resistance training group only
[56]. The authors speculated this combined training pro-
gram uniquely resulted in favorable adaptations in glu-
cose metabolism at the cellular level [56].
In the present study, we observed that changes in peak
VO2 could predict 21 % of the changes expected for
HbA1c, which can explain the link between metabolic
profile and exercise performance using the CART pro-
gram. In parallel, Sénéchal et. al. reporting results from
the HART-D study, demonstrated an association be-
tween the change in VO2 (quantified by estimated peak
METs) and a reduction in central adiposity were the
most prominent predictors of the change in HbA1c in
response to a 9-month ET program [54].
Effect of CART on Muscle and Endurance Strength
It is already known that the skeletal muscle is respon-
sible for approximately 75 % of whole body insulin-
stimulated glucose uptake [57]. In the current study,
after CART, the subjects showed improved muscle
strength, demonstrated by peak of torque to body weight
ratio (increase of 17.2 % in extensor and 32 % in flexor)
as well as improved endurance of leg flexors (26 %).
These results, associated with a reduction in thigh skin-
fold measurements, we speculated may indicate an in-
crease in muscle mass, although direct measurements of
lean mass gains were not explored in this study. This
finding also has a high clinical relevance, particularly
considering a decreased muscle mass is considered to be
a major impairment among patients with T2D [58]. Our
findings are also consistent with Maiorana et al., investi-
gating the effect of a short-term 8-week circuit training
Table 4 Cardiopulmonary exercise testing responses pre and post 3 months
Variables SG (N = 20) CART-G (N = 21) Time factor Exercise factor Interaction
CPX (peak) Pre Post Pre Post
Workload (watts) 123.6 ± 36.9 122.1 ± 32.9 124.6 ± 29.1 149.9 ± 29‡† 0.19 <0.001 <0.001
VE (l min
−1) 74.2 ± 21.2 62.8 ± 14.0 72.4 ± 15.2 80.6 ± 13.7‡† 0.12 0.53 <0.001
VO2 (ml kg
−1 min−1) 21.7 ± 4.5 21 ± 3.3 22.9 ± 6.1 27.2 ± 4.7‡† 0.02 0.02 0.002
VO2 (ml min
−1) 1935.7 ± 581.1 1796.9 ± 485.4 2074 ± 443.8 2323.3 ± 523.8‡† 0.38 0.05 0.004
VO2 (ml min
−1) % pred 108.8 ± 21.3 102.3 ± 20.5 111.8 ± 24.6 125.5 ± 27‡† 0.28 0.09 0.004
VCO2 (ml min
−1) 2240.2 ± 612.6 2068.5 ± 444.1 2269.1 ± 478.7 2542.8 ± 485.5‡† 0.14 0.48 0.004
VE/VCO2 slope 32.6 ± 3.6 30.1 ± 3.1 31.6 ± 3.6 32.4 ± 3.1 0.55 0.17 0.006
RER 1.3 ± 0.1 1.2 ± 0.1 1.2 ± 0.1 1.2 ± 0.1 0.40 0.03 0.72
HR (bpm) 147.6 ± 13.9 139.9 ± 19.3 146.7 ± 12.9 149.8 ± 14.4 0.33 0.34 0.03
HR (bpm) % pred 91 ± 10 86 ± 15 84 ± 22 90 ± 11 0.36 0.95 0.03
O2 pulse (ml beat
−1) 10.5 ± 3.6 10.9 ± 3.4 11.7 ± 2.1 12.8 ± 3.1 0.08 0.12 0.07
Dyspnea (0–10) 5.1 ± 2.9 4.3 ± 2.1 5.4 ± 2.4 6.1 ± 1.6 0.07 0.86 0.09
Leg effort (0–10) 4.7 ± 2.9 4.4 ± 2.2 5.1 ± 2.6 5.8 ± 2.6 0.19 0.70 0.32
Data are reported as means ± SD. P ≤ 0.05, sedentary group pre × sedentary group post; ‡exercise group pre × exercise group post, †sedentary group post ×
exercise group post
Table 5 Isokinetic strength and endurance test responses pre and post 3 months
Variables SG (N = 20) CARTG (N = 21) Time factor Exercise factor Interaction
Isokinetic strength test Pre Post Pre Post
Peak torque extension (N m) 145.3 ± 47.9 143 ± 42.2 135.5 ± 41 159.7 ± 47.7‡ 0.82 0.002 <0.001
Peak torque flexion (N m) 74.8 ± 26.4 72.2 ± 24.3 72.1 ± 19.3 92 ± 24.1‡† 0.27 <0.001 <0.001
PT/BW extension (%) 174.6 ± 34.3 176.4 ± 23.3 167 ± 41.5 195.8 ± 43.6‡ 0.63 0.002 0.004
PT/BW flexion (%) 92.4 ± 19.8 89.5 ± 19.1 87.9 ± 14.7 116 ± 30.1‡† 0.10 0.001 <0.001
AVG power extension (watts) 90 ± 28 92 ± 27.3 86.8 ± 27 110.6 ± 31.8‡ 0.42 <0.001 <0.001
AVG power flexion (watts) 50.2 ± 21.2 50.3 ± 19.5 47.7 ± 14.2 66.5 ± 18.2‡† 0.25 <0.001 <0.001
Isokinetic endurance test
Total work extension (J) 2673.8 ± 960.3 2660.5 ± 895.2 2744 ± 783.8 3171.2 ± 1111.5 0.37 0.09 0.08
Total work flexion (J) 1325.2 ± 511.9 1343.2 ± 443.5 1340.3 ± 453.8 1685 ± 717.1‡† 0.33 0.03 0.05
Data are reported as means ± SD. PT/BW peak torque/body weight, AVG average force along the vertical axis. P ≤ 0.05, ‡exercise group pre × exercise group post,
†sedentary group post × exercise group post
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program composed by aerobic and resistance exercise
with T2D in a randomized crossover protocol, which ob-
served an increase of 12 % in muscle strength [59].
However, Church et al. did not observe a significant
improvement in peak torque and work in the combined
training program after 9 months.
Sousa et al., in a RCT evaluated the impact of different
exercise training modalities on functional fitness re-
sponses in apparently healthy older men, showing that
only the combined exercise program was effective in
improving all functional fitness components. It is note-
worthy to point out they used long-term training
(9 months) yet did not evaluate muscle strength [60].
Untrained individuals normally have rapid improve-
ments in muscle strength during the initial phases of a
training program, which are predominantly attributed to
a learning effect as well as neuromuscular adaptations
within the first 4 weeks of program initiation [61]. In
this context, our results can be explained by true adapta-
tions in muscle force production since the patients con-
tinued improving muscle strength throughout the
program. These aspects are important given a recent
study contrasting different ET protocols (i.e., aerobic
versus resistance) observed that only resistance exercise
had an important influence on maintaining reductions
in LDL-C, HbA1C and the increase in HDL-C, even if
the training program is interrupted for a short term [62].
Resistance training have been highly recommended by
the ACSM as an important tool to preserve/improve
muscle mass and potentially improve insulin sensitivity,
not only due to development of more muscle mass but
also due to improved muscle quality [63, 64]. Combining
aerobic with resistance training, alternating the training
each session can be an important alternative to preserve
gains of functional capacity and muscle strength status.
In fact, it has been shown that the supervised aerobic,
resistance or combined aerobic/resistance training are
associated with greater decreases in HbA1c compared to
exercise counseling alone or a singular training
Table 6 One-repetition maximum responses pre and post CART
1-RM test Pre (N = 21) Post (N = 21) P value
Lower body exercises
Leg press 127.6 ± 21.9 174.3 ± 34.9 0.0001
Leg extension (right) 41.3 ± 14.2 59.3 ± 15.9 0.003
Leg extension (left) 40.1 ± 12.6 58 ± 16 0.002
Calf 91.6 ± 21.8 131 ± 27.5 0.0002
Seated leg curl (right) 31.6 ± 11.2 43 ± 11.5 0.01
Seated leg curl (left) 31.9 ± 10.8 42 ± 9.5 0.021
Upper body exercises
Biceps 10.6 ± 2.2 13.7 ± 2.9 0.005
Flat bench press 39 ± 13 52.7 ± 15.1 0.017
Triceps 97.4 ± 20.7 120.8 0.001
Seated row 62.5 ± 18.2 84.3 ± 21.5 0.010
Data are reported as means ± SD. P ≤ 0.05
Fig. 2 Comparison between changes of VO2 (ml kg
−1 min−1) and changes HbA1c (mmol/mol) in response to 12 weeks of CART (filled circles) and
sedentary (open circles) in diabetic patients
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approach. Umpierre et al., in a systematic review with
meta-regression analysis of RCTs, found that the chronic
impact on glycemic control might be affected by volume
and intensity of the structured exercise program and not
only the mode of exercise training [65].
The main drawback of our study was the impossibility
to use a gold standard assessment to diagnose auto-
nomic function. This would have been valuable given
T2D has a negative impact on the autonomic control.
Assessing the effects of CART on autonomic function
would have been of value and should be performed in
future investigations. Another potential limitation was
the impossibility to have a gold standard body compos-
ition assessment, such as DEXA. Thus, the inferences re-
lated to these assessments in our study must be
confirmed by future investigations.
Conclusions
In conclusion, this study showed that a 12-week person-
alized and supervised concurrent ET program can
improve not only the VO2 and muscle performance,
but also glycemic control and body habitus. Future trials
are necessary to contrast different approaches to CART,
considering the effect on order of training program in
the T2D population.
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